Virtual Practice
Recommend

Dr. James Chapman

Internal Medicine - Cardiology
Grove, OK
About
Insights
Network
Welcome!
About me
I specialize in
Internal Medicine - Cardiology
Interventional Cardiology
Preventive Medicine
I have been in practice
39 years
I am licensed to see patients from
Oklahoma
I speak
English
I'm known for
Doctor
Votes
Member
Votes
Chest pain
23rd
Nationally
59
Heart attack
1st
Locally
32
Recommend me
My answers and insights have
Saved 12 lives
Helped 1,441,725 people
Received 2,299 doctor agrees
Received 809 thanks
Here are kind words from others
Dr. Chapman's responses are very much straight-forward and the reader does not get lost in medical-ese. Great style that more should emulate. Does not overburden the reader with unnecessary terminology or lengthy differential diagnoses that only a medically trained individual could understand. Keep up the great work!
Dr. Chapman provides an excellent public service through Health Tap.The information he provides is understandable, to the point, pertinent and accurate. He is clearly very knowledgable about Cardiology. I recommend Dr. Chapman.
I recommend Dr. Chapman highly. His contributions to HealthTap are outstanding.
Dr. Chapman's answers are clear, concise, and accurate.
Great responses. Very accurate. Comes highly recommended.
Very accurate and useful responses.
Recommend me
I am located at
Oklahoma Heart Institute
900 E 13th St
Suite 200
Grove , OK 74344
Office hours
Mon 8:00am - 5:00pm
Tue 8:00am - 5:00pm
Wed 8:00am - 5:00pm
Thu 8:00am - 5:00pm
Fri 8:00am - 5:00pm
Accepted Insurance Plans
BlueCross BlueShield
I was educated and trained at
Medical / Graduate School
Indiana University School of Medicine
Fellowships
Interventional Cardiology ST VINCENT HEART CENTER OF INDIANA LLC
I'm affiliated with
Hospitals
HILLCREST HOSPITAL
I've won the following awards
TOP CARDIOLOGIST, The Nation
2018
Top Cardiologist, Missouri
Fall 2017
Top Cardiologist, Missouri
Spring 2017
I've published
Use of Flow Support Device for Treatment of Complications of Coronary Angioplasty
FACT trial